drug-resistant tuberculosis

drug-resistant tuberculosis

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • Can you get TB care in the private sector? It is complicated

    In South Africa, tuberculosis is mainly diagnosed and treated in the public healthcare system. On paper, the private sector should also be able to deal with it, but in reality, TB care in this sector is often fragmented and confusing. Elri Voigt asks local experts why things work like this and what can be done…

    ·

  • “Someone had to do it”, says SA TB activist on Time 100 list

    At the age of 19 Phumeza Tisile contracted multidrug-resistant tuberculosis. For four years she battled the disease, losing her hearing in the process. At one stage, a doctor told her to visit a priest and prepare her soul for death. Recently, Tisile (now 33) made it on to TIME magazine’s 2023 TIME100 Next list, as…

    ·

  • What new WHO TB numbers mean for SA

    An estimated 54 000 people died of tuberculosis in South Africa in 2022 and around 280 000 fell ill with the disease, according to just-released figures from the World Health Organization. Catherine Tomlinson unpacks the figures and what they mean for the country’s TB response.

    ·

  • How does SA measure up against new TB recommendations?

    A new report from the Lancet Commission on Tuberculosis (TB) titled ‘Scientific advances and the end of tuberculosis’ makes several recommendations for how governments should go about fighting the deadly, but curable, disease. Spotlight editor Marcus Low puts the Spotlight on how South Africa’s TB programme is measuring up against the recommendations.

    ·

  • Shorter treatment regimens for TB offer hope, but await implementation

    Almost two years ago, a study found that a breakthrough four-month treatment regimen for tuberculosis is as effective as the current six-month regimen. The time is now to join together for the thoughtful implementation of this new regimen, argue Yuri F. van der Heijden, Violet Chihota, and Salome Charalambous.

    ·

  • Prof Muki Shey on his journey from Cameroon to doing cutting-edge TB research

    On 9 March, Professor Muki Shey received a silver award from the South African Medical Research Council for his “outstanding contribution to health research”. Shey is spearheading research into TB in healthcare workers from around Cape Town, scanning for those who over at least five years of high exposure to the disease at hospitals or…

    ·

  • Spotlight on Health: 2022 in under 1 000 words

    An HIV prevention injection approved in South Africa, several promising developments on the tuberculosis front, the National Health Insurance Bill grinding its way through Parliament, no end in sight to healthcare worker shortages, another dire year for health in Gauteng – Spotlight wraps up 2022 in under 1 000 words.

    ·

  • Francesca Conradie – from HIV to groundbreaking TB research

    Dr Francesca Conradie knew she wanted to be a doctor when she was eight years old. Now, 50 years later, she is a pioneer in the field of tuberculosis (TB) and led a landmark trial that changed how drug-resistant TB is treated. Aisha Abdool Karim spoke to her about the reasons behind her switch from…

    ·